Orit Foord
Impact in
-
- Cancer-related Molecular Pathways
-
- Cancer Research and Treatments
Papers in
- Oncology 7
- Cancer-related Molecular Pathways 4
- CAR-T cell therapy research 3
-
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 2
- Protein purification and stability 1
- Co-authors
- Varda Rotter (3 shared papers)Gretchen Argast (1 shared paper)Hagit Eldar-Finkelman (1 shared paper)E G Krebs (1 shared paper)Edmond H. Fischer (1 shared paper)Ziv Reich (1 shared paper)N. Navot (3 shared papers)Elise Rose (1 shared paper)
- Journals
- Molecular and Cellular Biology (2 papers)Cancer Research (2 papers)The Journal of Immunology (1 paper)Investigational New Drugs (1 paper)Trends in Cell Biology (1 paper)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
Orit Foord
10 papers receiving 424 citations
Peers
Comparison fields: 5 of 59
- Oncology 172
- Biotechnology 45
- Molecular Biology 299
- Epidemiology 77
- Radiology, Nuclear Medicine and Imaging 48
Countries citing papers authored by Orit Foord
This map shows the geographic impact of Orit Foord's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orit Foord with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orit Foord more than expected).
Fields of papers citing papers by Orit Foord
This network shows the impact of papers produced by Orit Foord. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orit Foord. The network helps show where Orit Foord may publish in the future.
Co-authors
The 25 scholars most cited alongside Orit Foord, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 116 | |
| 2 | 1991 | 91 | |
| 3 | 2009 | 79 | |
| 4 | 1993 | 31 | |
| 5 | 1993 | 25 | |
| 6 | 2004 | 25 | |
| 7 | 1994 | 23 | |
| 8 | 2009 | 20 | |
| 9 | 2023 | 16 | |
| 10 | 1993 | 10 | |
| 11 | 2022 | 0 | |
| 12 | 2025 | 0 | |
| 13 | 2022 | 0 |
About Orit Foord
Orit Foord is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Biotechnology and Immunology, having authored 13 papers that have together received 436 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Epigenetics and DNA Methylation (3 papers), CAR-T cell therapy research (3 papers), Cancer Research and Treatments (2 papers), RNA modifications and cancer (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Protein purification and stability (1 paper) and Animal Virus Infections Studies (1 paper). The work is most often cited by research in Oncology (172 citations), Biotechnology (45 citations), Molecular Biology (299 citations), Epidemiology (77 citations) and Radiology, Nuclear Medicine and Imaging (48 citations). Orit Foord has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Varda Rotter, Gretchen Argast, Hagit Eldar-Finkelman, E G Krebs, Edmond H. Fischer, Ziv Reich, N. Navot, Elise Rose, Bruce A. Keyt and Ralph A. Tripp. Their work appears in journals such as Molecular and Cellular Biology, Cancer Research, The Journal of Immunology, Investigational New Drugs and Trends in Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.